In the past few weeks alone, Perfluoroalkyl and Polyfluoroalkyl Substances (PFAS) have appeared in headlines for very different reasons.
The US government has moved to roll back drinking water limits for several PFAS compounds.
In the UK, MPs have called for restrictions on PFAS in uniforms and cookware. Researchers at the University of Portsmouth have reported elevated PFAS concentrations in harbour porpoises from the Solent.
Meanwhile, Australia has launched legal action against 3M seeking more than A$2 billion over environmental contamination linked to PFAS-containing firefighting foam.
At first glance, these developments appear unrelated. In reality, they point to a growing challenge for manufacturers, product stewards and Environment, Health, and Safety (EHS) leaders: PFAS risk is no longer defined by a single regulation, market or enforcement action.
The debate has entered a new phase. Regulatory approaches are diverging, litigation is accelerating and expectations around chemical transparency continue to rise.
Against this backdrop, many organisations are still struggling to answer a surprisingly basic question: do we actually know where PFAS sits in our products and supply chains?
Regulatory uncertainty does not reduce exposure
It can be tempting to view changes in regulation as a signal that pressure is easing. Yet for globally operating businesses, the reality is often the opposite.
Manufacturers today navigate overlapping obligations across multiple jurisdictions, from Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) requirements and national restrictions to customer specifications, procurement requirements and sustainability disclosures.
A policy shift in one market does not eliminate expectations elsewhere. Nor does it remove scrutiny from investors, customers or regulators asking for greater transparency around chemical content.
The challenge is compounded by the fact that PFAS is not a single substance. It is a broad family of thousands of chemicals, and different jurisdictions define and regulate them in different ways. As policymakers continue to debate where restrictions should apply and how they should be enforced, organisations are left managing a moving target.
For many businesses, the question is no longer whether PFAS regulation will affect them. It is how quickly they can adapt when expectations change.
The visibility challenge hiding in plain sight
The greatest difficulty is often not regulatory interpretation. It is visibility.
Many organisations do not have a complete picture of the substances present across their products, components and supplier networks. PFAS compounds can appear under different names, may not always be obvious from safety documentation and can enter products through multiple tiers of suppliers.
As a result, businesses frequently find themselves working from assumptions rather than evidence.
Key questions become difficult to answer with confidence:
Which PFAS substances are present in our products?
Which suppliers contribute them?
Are they intentionally added or present through raw materials?
Which products and markets are affected?
Can we demonstrate compliance if challenged?
These are not hypothetical concerns. They already shape commercial decisions, customer relationships and procurement outcomes. When an organisation cannot answer these questions quickly and accurately, every regulatory update becomes a fire drill.
Litigation is changing the conversation
Historically, discussions around PFAS focused largely on regulatory compliance. Today, organisations are increasingly being asked to demonstrate what they knew, when they knew it and what evidence supported their decisions. This changes the nature of risk.
Companies are no longer judged solely on whether they complied with a specific requirement at a specific point in time. They may also face questions about the robustness of their chemical governance processes, supplier oversight and data management practices.
The ability to produce credible, traceable information is becoming progressively more important. In other words, chemical transparency is evolving from a compliance exercise into a business resilience issue.
Building continuous visibility
Leading organisations are responding by investing in stronger chemical data foundations. Rather than treating PFAS as a one-off compliance project, they are building systems and processes that provide ongoing visibility into substances, suppliers and product composition.
They are strengthening supplier engagement, improving access to formula-level information and adopting lifecycle-based approaches that help identify risk earlier.
Advances in digital technologies and AI are also helping organisations analyse large volumes of supplier and product data more efficiently, identify information gaps and respond more quickly when regulations change.
The objective is not to predict every future policy development, but instead to ensure that when new restrictions emerge, customer expectations shift, or questions arise, the organisation already has the information it needs to respond confidently.
Visibility will separate leaders from laggards
PFAS is unlikely to be the last chemical issue that tests organisations in this way. The broader trend is that regulators, customers and investors increasingly expect businesses to understand the substances present in their products, demonstrate effective oversight and provide credible evidence to support their claims.
Those expectations are unlikely to diminish, regardless of how individual regulations evolve.
Organisations that invest in chemical transparency today will be better positioned to respond to future change, reduce disruption and build trust across their value chains.
Because in today’s environment, the biggest risk is not necessarily the presence of PFAS but discovering too late that your organisation cannot prove what it knows about i
